Agilent Technologies revenue
Agilent Technologies's revenue was $6.95bn in fiscal 2025, up 6.7% on the year before. Since fiscal 2009 ($4.48bn) it has grown at a compound 2.8% a year. Over the last twelve months it was $7.37bn.
Revenue history
| Fiscal year | 2009Oct 2009 | 2010Oct 2010 | 2011Oct 2011 | 2012Oct 2012 | 2013Oct 2013 | 2014Oct 2014 | 2015Oct 2015 | 2016Oct 2016 | 2017Oct 2017 | 2018Oct 2018 | 2019Oct 2019 | 2020Oct 2020 | 2021Oct 2021 | 2022Oct 2022 | 2023Oct 2023 | 2024Oct 2024 | 2025Oct 2025 | LTMJul 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 4,481 | 5,444 | 6,615 | 6,858 | 3,894 | 4,048 | 4,038 | 4,202 | 4,472 | 4,914 | 5,163 | 5,339 | 6,319 | 6,848 | 6,833 | 6,510 | 6,948 | 7,372 |
| Growth on the year before | — | +21.5% | +21.5% | +3.7% | −43.2% | +4.0% | −0.2% | +4.1% | +6.4% | +9.9% | +5.1% | +3.4% | +18.4% | +8.4% | −0.2% | −4.7% | +6.7% | — |
| Gross profit | 2,292 | 2,930 | 3,529 | 3,604 | 1,907 | 1,976 | 2,041 | 2,197 | 2,409 | 2,680 | 2,805 | 2,837 | 3,407 | 3,722 | 3,465 | 3,535 | 3,643 | 3,968 |
| Gross margin | 51.1% | 53.8% | 53.3% | 52.6% | 49.0% | 48.8% | 50.5% | 52.3% | 53.9% | 54.5% | 54.3% | 53.1% | 53.9% | 54.4% | 50.7% | 54.3% | 52.4% | 53.8% |
Where the revenue comes from
| Line of business | Revenue | Share | YoY |
|---|---|---|---|
| Agilent Cross Lab | $2.9B | 41.9% | ▲ 5.9% |
| Life Sciences and Diagnostics Markets | $2.7B | 39.2% | ▲ 10.5% |
| Applied Markets | $1.3B | 18.9% | ▲ 1.3% |
| Line of business | Revenue | YoY |
|---|---|---|
| Products | $4.9B | ▲ 5.8% |
| Non Instrumentation and Other | $4.5B | ▲ 8.8% |
| Instrumentation | $2.4B | ▲ 3.1% |
| Other services | $2B | ▲ 9.0% |
These categories overlap or exclude eliminations, so shares aren't shown.
| Region | Revenue | YoY |
|---|---|---|
| Rest of World | $3.4B | ▲ 11.0% |
| Americas | $2.8B | ▲ 9.1% |
| United States | $2.3B | ▲ 4.3% |
| Asia Pacific | $2.2B | ▲ 2.4% |
| Europe | $1.9B | ▲ 8.6% |
| China | $1.2B | ▲ 0.6% |
These categories overlap or exclude eliminations, so shares aren't shown.
From Agilent Technologies's 10-K filed December 22, 2025, as tagged in the filing. View filing. Indented rows are part of the line above; their share is of that line. In the bars, the faint bar behind is the year before.
Revenue against peers
| Company | Revenue | Growth | 3-year growth a year |
|---|---|---|---|
| Agilent Technologies | $7.37bn | 8.6% | 1.8% |
| Avantor, Inc. | $6.64bn | 0.9% | -1.9% |
| Icon PLC | $8.25bn | 0.8% | 83.5% |
| Waters Corporation | $4.64bn | 52.5% | 15.8% |
| Illumina, Inc. | $4.54bn | 5.8% | 0.5% |
| Mettler Toledo | $4.13bn | 6.9% | 1.5% |
Compare with peers
More: Life Sciences Tools & Services stocks compared, Health Care sector, rankings of US companies